Congestive Heart FailurePhase 3NCT00071331
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
A Phase 3 study testing Tolvaptan in people with Congestive Heart Failure, run by Otsuka Pharmaceutical Development & Commercialization, Inc. at 378 sites in 18 countries.
Trial summary
The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Congestive Heart Failure
- What is being tested?
- Tolvaptan
- How many people
- 3,600 participants
- Where
- 378 sitesin 18 countries
- Study dates
- Sep 2003to Jul 2006
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age greater than or equal to 18 years.
- Current hospitalization for chronic congestive heart failure with admission up to 48 hours prior to randomization. Chronic heart failure is defined as requiring treatment for a minimum of 30 days prior to hospitalization.
- The subject must have signs of extracellular volume expansion, defined as two or more of the following: a) jugular venous distention; b) pitting edema (>1+); or c) dyspnea.
- NYHA Class III or IV at the time of hospitalization.
- Left Ventricular Ejection Fraction < = 40% within one year.
Who cannot join
- Women who will not adhere to the reproductive precautions as outlined in the Informed Consent form.
- Positive urine pregnancy test.
- Inability to provide written informed consent.
- Cardiac surgery within 60 days of potential study enrollment, excluding percutaneous coronary interventions.
- Planned revascularization procedures, electrophysiologic (EP) device implantation, cardiac mechanical support implantation, cardiac transplantation, or other cardiac surgery within 30 days following study enrollment.
- Subjects who are on cardiac mechanical support.
Show all 27Show fewer
- History of bi-ventricular pacer placement within the last 60 days.
- Co-morbid condition with an expected survival less than six months.
- Subjects with acute ST segment elevation myocardial infarction at the time of hospitalization.
- History of sustained ventricular tachycardia or ventricular fibrillation within 30 days, unless in the presence of an automatic implantable cardioverter defibrillator.
- History of a cerebrovascular accident within the last 30 days.
- Hemodynamically significant uncorrected primary cardiac valvular disease.
- Hypertrophic cardiomyopathy (obstructive or non-obstructive).
- CHF due to uncorrected thyroid disease, active myocarditis or known amyloid cardiomyopathy.
- Subjects with progressive or episodic neurological disease such as multiple sclerosis or history of multiple strokes.
- History of primary significant liver disease or acute hepatic failure, as defined by the investigator.
- History of poorly controlled diabetes mellitus.
- Morbid obesity, defined as > 159 kg (or 350 lbs) or BMI > 40.
- Supine systolic arterial blood pressure < 90 mmHg.
- Serum creatinine > 3.5 mg/dL or > 309.4 mmol/L.
- Serum potassium > 5.5 mEq/L or > 5.5 mmol/L.
- Hemoglobin < 9 g/dL or < 90 g/L.
- History of hypersensitivity and/or idiosyncratic reaction to benzazepine derivatives (such as benazapril).
- History of drug or medication abuse within the past year, or current alcohol abuse.
- Inability to take oral medications.
- Participation in another clinical drug or device trial within the past 30 days.
- Previous participation in this or any other tolvaptan clinical trial.
Trial locations and contacts
378 sites in 18 countries.
378 sites in 18 countries
United States161 sites
Akron General Medical Center
Akron, Ohio, 44307
Albany Associates in Cardiology
Albany, New York, 12212
Asheville Cardiology Associates
Asheville, North Carolina, 28803
Cardiac Disease Specialists PC
Atlanta, Georgia, 30309
Atlanta Heart and Vascular Research Group
Atlanta, Georgia, 30342
Florida Cardiovascular Research
Atlantis, Florida, 33462
Androscoggin Cardiology Associates
Auburn, Maine, 04210
Austin Cardiovascular Associates
Austin, Texas, 78705
Primary Care Cardiology Research
Ayer, Massachusetts, 01432
Bakersfield Memorial Hospital
Bakersfield, California, 93301
Central Cardiology Medical Center
Bakersfield, California, 93301
MidAtlantic Cardiovascular Associates
Baltimore, Maryland, 21218
Midatlantic Cardiovascular Associates
Baltimore, Maryland, 21229
MidAtlantic Cardiovascular Associates
Baltimore, Maryland, 21237
Northeast Cardiology Associates
Bangor, Maine, 04401
North Shore Cardiologists
Bannockburn, Illinois, 60015
Southeast Texas Cardiology Associates
Beaumont, Texas, 77702
Midatlantic Cardiovascular Associates
Bel Air, Maryland, 21014
University of Alabama at Birmingham
Birmingham, Alabama, 35294
Idaho Cardiology Associates
Boise, Idaho, 83704
Massachusetts General Hospital
Boston, Massachusetts, 02114
Beth Israel Medical Center
Boston, Massachusetts, 02215
Alamance Regional Medical Center
Burlington, North Carolina, 27215
Clinical Research Limited
Canton, Ohio, 44718
The Louisiana Heart Center
Chalmette, Louisiana, 70043
University of North Carolina
Chapel Hill, North Carolina, 27514
Medical University of South Carolina
Charleston, South Carolina, 29401
Ralph H. Johnson VAMC
Charleston, South Carolina, 29401
CAMC Clinical Trials
Charleston, West Virginia, 25304
Mid Carolina Cardiology
Charlotte, North Carolina, 28204
University of Virginia Medical Center
Charlottesville, Virginia, 22908
The Chattanooga Heart Institute
Chattanooga, Tennessee, 37404
Northwestern University
Chicago, Illinois, 60611
Sterling Research Group
Cincinnati, Ohio, 45219
The Lindner Clinical Trial Center
Cincinnati, Ohio, 45219
Missouri Cardiovascular Specialists
Columbia, Missouri, 65201
South Carolina Heart Center
Columbia, South Carolina, 29204
Midwest Cardiology Research Foundation
Columbus, Ohio, 43214
Georgia Heart Specialists
Covington, Georgia, 30014
Northshore Medical Research
Covington, Louisiana, 70433
Cardiopulmonary Research Science and Technology Institute
Dallas, Texas, 75230
The Dayton Heart Center
Dayton, Ohio, 45414
Aurora Denver Cardiology Associates
Denver, Colorado, 80218
University of Colorado
Denver, Colorado, 80262
John Dingell VA Medical Center
Detroit, Michigan, 48201
Durham VA Medical Center
Durham, North Carolina, 27705
Duke Cardiology Research
Durham, North Carolina, 27710
Shore Health System
Easton, Maryland, 21601
Wisconsin Center For Clinical Research
Elkhorn, Wisconsin, 53121
The Cardiovascular Group PC
Fairfax, Virginia, 22031
Cleveland Cardiovascular Research
Fairview Park, Ohio, 44126
Inova Institute of Research
Falls Church, Virginia, 22042
Heart and Vascular Clinic of North Colorado
Fort Collins, Colorado, 80528
Cardiology Associates of Fort Lauderdale
Fort Lauderdale, Florida, 33308
University of Texas Medical Branch
Galveston, Texas, 77555-0553
Phoenix Memorial Hospital
Gilbert, Arizona, 85233
Pitt County Memorial Hospital, The Heart Center
Greenville, North Carolina, 28735
Hendersonville Cardiology
Hendersonville, North Carolina, 28739
Leonard J Chabert Medical Center
Houma, Louisiana, 70360
The Heart Center
Huntsville, Alabama, 35801
The Care Group
Indianapolis, Indiana, 46260
Jacksonville Heart Center
Jacksonville, Florida, 32207
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
Jacksonville Heart Center
Jacksonville Beach, Florida, 32250
Cardiology Associates, P.C.
Johnson City, New York, 13790
Mid America Cardiology
Kansas City, Kansas, 66160
VA Medical Center- Kansas City
Kansas City, Missouri, 64128
Cardiovascular Associates
Kingsport, Tennessee, 37660
Cardiology Associates
Larkspur, California, 94939
Bryan LGH Heart Institute
Lincoln, Nebraska, 68516
Central Arkansas Veterans Healthcare Systems
Little Rock, Arkansas, 72205
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
Loma Linda University Medical Center
Loma Linda, California, 92354
Midwest Heart Research Found.
Lombard, Illinois, 60148
North Ohio Research Limited
Lorain, Ohio, 44052
LAC/USC Medical Center
Los Angeles, California, 90033
VA Medical Center- W. Los Angeles
Los Angeles, California, 90073
Cardiovascular Associates
Louisville, Kentucky, 40205
Louisville Cardiology Medical Group
Louisville, Kentucky, 40207
Cardiology Associates Covenant Medical Group
Lubbock, Texas, 79410
New England Heart Institute
Manchester, New Hampshire, 03102
North Shore University Hospital
Manhasset, New York, 11030
McAllen Heart Clinic
McAllen, Texas, 78503
Melbourne Internal Medicine Assoc.
Melbourne, Florida, 32901
Baptist Clinical Research Center
Memphis, Tennessee, 38120
Stern Cardiovascular Center
Memphis, Tennessee, 38120
Idaho Cardiology Associates
Meridian, Idaho, 83642
University of Miami/ Jackson Memorial Hospital
Miami, Florida, 33136
Miami Research and Education Foundation
Miami, Florida, 33156
Minneapolis Heart Institute
Minneapolis, Minnesota, 55407
Hennepin County Medical Center
Minneapolis, Minnesota, 55416
University of Minnesota
Minneapolis, Minnesota, 55455
Mission Internal Medical Group
Mission Viejo, California, 92691
The Heart Group
Mobile, Alabama, 36608
Morristown Memorial Hospital
Morristown, New Jersey, 07962-1956
Vanderbilt Clinical Trials Center
Nashville, Tennessee, 37212
St. Vincents Hospital and Medical Center
New York, New York, 10011
St. Lukes-Roosevelt Hospital Centers
New York, New York, 10019
New York Presbyterian Hospital
New York, New York, 10032
Christiana Care Health System
Newark, Delaware, 19718
University of Medicine and Dentistry of New Jersey
Newark, New Jersey, 07103
Newark Beth Israel Medical Center
Newark, New Jersey, 07112
Illinois Heart & Lung Associates
Normal, Illinois, 61761
Bakus Resesarch
Norwich, Connecticut, 06360
Ocala Resarch Institute
Ocala, Florida, 34480
Integris Heart Research Center
Oklahoma City, Oklahoma, 73112
Oklahoma Cardiovascular Research Group
Oklahoma City, Oklahoma, 73120
Heart Consultants
Omaha, Nebraska, 68122
Cardiology Research Associates
Ormond Beach, Florida, 32174
Garden State Cardiology
Paramus, New Jersey, 07652
Heart Care Midwest
Peoria, Illinois, 61603
Nisus Research
Petoskey, Michigan, 49770
Cardiology Consultants of Philadelphia
Philadelphia, Pennsylvania, 19146
Arizona Heart Institute
Phoenix, Arizona, 85006
The Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, 15224
Charlotte Heart Group Research Center
Port Charlotte, Florida, 33952
Maine Medical Center
Portland, Maine, 04102
Oregon Health and Science University
Portland, Oregon, 97230
Rhode Island Hospital
Providence, Rhode Island, 02905
ARI Clinical Trials
Redondo Beach, California, 92077
Medical College of Virginia
Richmond, Virginia, 23219
Cardiovascular Associates of Virginia
Richmond, Virginia, 23225
Roanoke Heart Institute
Roanoke, Virginia, 24014
Mayo Clinic, Division of Cardiology
Rochester, Minnesota, 55905
St. Francis Hospital
Roslyn, New York, 11576
William Beaumont Hospital
Royal Oak, Michigan, 48073-1026
Covenant Medical Center
Saginaw, Michigan, 48602
Park Nicollet Heart Center
Saint Louis Park, Minnesota, 55426
Regions Hospital Cardiology Research
Saint Paul, Minnesota, 55101
St. Paul Heart Clinic
Saint Paul, Minnesota, 55102
VA Salt Lake City Health Care System
Salt Lake City, Utah, 84148
University of Texas Health Science Center
San Antonio, Texas, 78229-3900
Wilford Hall Medical Center,
San Antonio, Texas, 78236
San Diego Cardiac Center
San Diego, California, 92123
North Ohio Research Limited
Sandusky, Ohio, 44870
Pacific Heart Institute
Santa Monica, California, 90404
Cardiovascular Center of Sarasota
Sarasota, Florida, 34239
Guthrie Clinic, LTD
Sayre, Pennsylvania, 18840
Buxmont Cardiology Associates, PC
Sellersville, Pennsylvania, 18960
Lousiana State University Health Sciences Center
Shreveport, Louisiana, 71103
Cardiac Centers of LA, LLC
Shreveport, Louisiana, 71135
Empire Health Services
Spokane, Washington, 99204
Rockwood Clinic
Spokane, Washington, 99204
St. Louis University
St Louis, Missouri, 63110
The Heart and Vascular Institute of Florida
St. Petersburg, Florida, 33701
SUNY
Syracuse, New York, 13230
Scott & White Clinic Division of Cardiology
Temple, Texas, 76508
Northwest Ohio Cardiology Consultants
Toledo, Ohio, 43615
MidAtlantic Cardiovascular Associates
Towson, Maryland, 21204
Heart Associates, P.A.
Towson, Maryland, 21286
Beaumont Hospital
Troy, Michigan, 48085
Saguaro Clinical Research
Tucson, Arizona, 85712
The Cardiology Group
Tullahoma, Tennessee, 37388
Cardiology Associates of North Mississippi
Tupelo, Mississippi, 38801
Cardiovascular Consultants Medical Group, Inc.
Walnut Creek, California, 94598
VA Medical Center
Washington D.C., District of Columbia, 20422
South Bay Cardiovascular Associates
West Islip, New York, 11795
Cardiology Associates of West Reading
West Reading, Pennsylvania, 19611
MidAtlantic Cardiovascular Associates
Westminster, Maryland, 21157
Buffalo Cardiology and Pulmonary Associates
Williamsville, New York, 14221
Michigan Heart
Ypsilanti, Michigan, 48197
Russia24 sites
Botkins Moscow City Hospital
Moscow
Burdenko Main Military Clinical Hospital
Moscow
Cardiology Research Center
Moscow
Central Clinical Hospital Presidential
Moscow
City Clinical Hospital 2
Moscow
Institute of Physico-Chemical Medicine
Moscow
Medical Center of General Management
Moscow
Moscow Medical Academy
Moscow
Moscow Regional Research Clinical Institute n.a. Vishnevsky
Moscow
Moscow State University of Medicine and Dentistry - City Hospital #11
Moscow
Moscow State University of Medicine and Dentistry - City Hospital #40
Moscow
Moscow State University of Medicine and Dentistry
Moscow
Russian State Medical University
Moscow
Veterans Hospital #3
Moscow
Cardiology Research Institute of the Ministry of Health of the Russian Federation
Saint Petersburg
City Alexandrovsky Hospital, ICU Department
Saint Petersburg
City Hospital #31
Saint Petersburg
City Hospital 8
Saint Petersburg
Military Medical Academy
Saint Petersburg
St. Elisabeth City Hospital
Saint Petersburg
St. Petersburg Clinical Hospital of Russian Academy of Sciences
Saint Petersburg
St. Petersburg Dzanelidze State Scientific Research Institute for Emergency Medical Care
Saint Petersburg
St. Petersburg Medical Postgraduate Academy
Saint Petersburg
St. Petersburg State University
Saint Petersburg
Germany21 sites
Klinikum Augsburg
Augsburg
Herzzentrum Bad Krozingen
Bad Krozingen
Herz- und Gefabklinik Bad Neustadt
Bad Neustadt-Saale
Vivantes Klinikum Neukoln
Berlin
Klinikum der Universitat zu Koln
Cologne
Akademisches Lehrkrankenhaus d. HGS Essen
Essen
Universitatsklinik Essen
Essen
Georg-August-Universitat Gottingen
Göttingen
Universitatsklinikum der
Greifswald
Klinikum der Medizinischen Fakultat
Halle
Universitatsklinikum Eppendorf
Hamburg
Medizinische Universitätsklinik
Heidelberg
Universitatsklinikum Heidelberg
Heidelberg
Universitatsklinikum des Saarland
Homburg/Saar
Friedrich Schiller Universitat Jena
Jena
University Leipzig
Leipzig
Universitatsklinikum Munster
Münster
Herz- und Diabetes Zentrum Nordrhein-Westfalen
Oeyenhausen
Universitat Regensburg
Regensburg
Marienkrankenhaus Soest
Soest
Robert-Bosch-Krankenhaus
Stuttgart
Argentina20 sites
Clinica Constituyentes de Moron
Buenos Aires
Clinica Modelo de Moron
Buenos Aires
Fundacion Favaloro
Buenos Aires
Hospital Argerich
Buenos Aires
Hospital Churruca
Buenos Aires
Hospital Eva Peron
Buenos Aires
Hospital Nacional Dr. Alejandro Posadas
Buenos Aires
Hospital de Clinicas
Capital Federal
Hospital Fernandez
Capital Federal
Hospital Italiano de Buenos Aires
Capital Federal
Hospital Privado Antartida
Capital Federal
Hospital Ramos Mejia
Capital Federal
Policlinica Bancaria
Capital Federal
Sanatorio Municipal "Julio A. Mendez"
Capital Federal
Hospital Allende
Córdoba
Hospital Italiano de Cordoba
Córdoba
Hospital Militar de Cordoba
Córdoba
Hospital Privado Centro Medico de Cordoba
Córdoba
Instituto de Cardiologia J. F. Cabral
Corrientes
Hospital Central de San Isidro
San Isidro
Canada20 sites
Brampton Research Associates
Brampton, Ontario, L6V1B4
Peter Loougheed Center
Calgary, Alberta, T1Y6J4
Centre Hospitalier de l'Universite de Sherbrooke
Fleurimond, Quebec, J1H 5N4
CHRDL
Joliette, Quebec, J6E6J2
Invascor Clinical Research
Longueuil, Quebec, J4M 1E1
Montreal Heart Institute
Montreal, Quebec, H1T1C8
Royal Victoria Hospital
Montreal, Quebec, H3A1A1
Montreal General Hospital
Montreal, Quebec, H3G 1A4
Greater Niagara General Hospital
Niagara Falls, Ontario, L2E6Y2
Lakeridge Health Oshawa
Oshawa, Ontario, L1G2B9
Hotel-Dieu de Saint-Jerome
Saint-Jérôme, Quebec, J7Z 5T3
Scarborough Cardiology Research
Scarborough Village, Ontario, M1E5E9
Cardiology Research Associates
Scarborough Village, Ontario, M2S4V5
Health Sciences Center
St. John's, Newfoundland and Labrador, A1B 3V6
Surrey Memorial Hospital
Surrey, British Columbia, V3V1Z2
The Scarborough Hospital
Toronto, Ontario, M1P 2V5
St. Michael's Hospital
Toronto, Ontario, M5B 1W8
University Health Network, Toronto Western Hospital
Toronto, Ontario, M5G 2C4
Victoria Heart Institute Foundation
Victoria, British Columbia, V8R4R2
St. Boniface General Hospital
Winnipeg, Manitoba, R2H 2A6
Brazil19 sites
Hospital Governador Israel Pinheiro
Belo Horizonte, Minas Gerais, 30130-110
Santa Casa de Misericordia de Belo Horizonte
Belo Horizonte, Minas Gerais, 30150-221
Hospital e Maternidade Celso Pierro
Campinas, São Paulo, 13059-740
Hospital Evangelico de Curitiba
Curitiba, Paraná, 80730-150
Hospital Nossa Senhora das Gracas
Curitiba, Paraná, 80810-040
Hospital das Clinicas da Universidade Federal de Goias
Goiânia, Goiás, 74605-050
Hospital Universitario Onofre Lopes
Natal, 59012-310
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90020-090
Hospital das Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-003
Hospital Mae de Deus
Porto Alegre, Rio Grande do Sul, 90880-480
Hospital Nossa Senhora da Conceica
Porto Alegre, Rio Grande do Sul, 91350-200
Hospital das Clínicas de Porto Alegre
Porto Alegre, 90035-003
Santa Casa de Misericordia do Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, 20020-020
Hospital Universitario Pedro Ernesto
Rio de Janeiro, 20551-030
Hospital Santa Isabel da Santa Casa de Misericordia da Bahia
Salvador, Estado de Bahia, 40050-410
Fundacao Bahiana de Cardiologia- Hospital Universitario Professor Edgard Santos
Salvador, Estado de Bahia, 40140-060
Hospital de Base da Faculdade de Medicina de Sao Jose do Rio Preto
Sao Jose de Rio Preto, São Paulo, 15090-020
IMC- Instituto de Molestias Cardiovasculares
São José do Rio Preto, São Paulo, 15015-210
Instituto do Coracao do Hospital das Clinicas- Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, São Paulo, 05403-000
Italy15 sites
Ospedale Civile S. Giuseppe
Albano Laziale
Azienda Ospedaliera S. Michele
Cagliari
Ospedale Civile
Capri city
Azienda USL n. 6 Ospedale Civile
Cecina
Poliambulatorio Valdichiana Ospedale di Cortona
Cortona
Centro Cardiologico Monzino
Milan
Ospedale Nigaurda Ca Granda
Milan
Fondazione Salvatore Maugeri
Montescano
Presidio Ospedaliero Villa Sofia
Palmero
Ospedali Riunti
Parma
IRCCS Policlinico S. Matteo
Pavia
IRCCS- Fondazione Salvatore Maugeri
Pavia
Ospedale S. Maria delle Grazie
Pozzuoli
Ospedale S. Bartolomeo
Sarzana
Ospedali Civile SS Annunziata
Sassari
Netherlands14 sites
Jeroen Bosch Ziekenhus (location Groot Ziekengasthius=GZG)
's-Hertogenbosch
Sint Lucas Andreas Ziekenhuis (loc. Lucas)
Amsterdam
Gelre Ziekenhuis (location Juliana)
Apeldoorn
Ziekenhuis Gooi Noord
Blaricum
Deventer Ziekenhuis
Deventer
Ziekenhuis Gelderse Vallei
Ede
Medisch Spectrum Twente
Enschede
Oosterschelde Ziekenhuizen
Goes
Martini Ziekenhuis (Loc. Martini Paviljoen)
Groningen
Spaarne Ziekenhuis
Heemstede
Ziekenhuis Hilversum
Hilversum
Canisius-Wilhelmina Ziekenhuis
Nijmegen
Medisch Centrum Haaglanden (location Westeinde)
The Hague
Isala Klinieken (Loc. Sophia)
Zwolle
Poland14 sites
Oddzial Kardiologii
Bydgoszcz
Oddzial Kardiologii
Krakow
Oddzial Kardiologii
Lodz
Oddzial Chorob Wewnetrznych
Oława
Oddzial Kardiologiczny
Opole
Oddzial Kardiologii
Ostrowiec Świętokrzyski
Oddzial Kardiologiczny
Piotrkow Trybunalski
Oddzial Kardiologiczny
Płock
Oddzial Kardiologii
Sieradz
Oddzial Kardiologii
Torun
Katedra i Oddzial Kliniczny Kardiologii Slaskiej Akademii
Tychy
I Klinika Choroby Wiencowej
Warsaw
Katedra i Klinika Chorab Wewnetrznych i Kardiologii
Warsaw
Oddzial Kardiologii
Włocławek
Czechia13 sites
I. interni kardio-angiologicka klinika LF MU
Brno
Interni oddeleni
Jablonec nad Nisou
Interni oddeleni
Náchod
Interni klinika, Oddeleni Interna I, Kardiologie
Pardubice
Interni oddeleni
Písek
I.Interni klinika
Plzen-Lochotin
I.Interni oddeleni
Prague
II.Interni klinika
Prague
Kardiologicka klinika
Prague
Kardiologicke oddeleni
Prague
Klinika kardiologie
Prague
Interni oddeleni
Ústí nad Labem
Interni klinika IPVZ
Zlín
France12 sites
Centre Hospitalier Regional d'Arras-Service de Cardiologie
Arras
Hopital General Henri Duffaut
Avignon
Centre Hospitalier Jeanne d'Arc
Bar-le-Duc
Hopital Louis Pradel
Bron
Cabinet de Cardiologie et d'Explorations
Essey-lès-Nancy
Centre Hospitalier
Langres
CHU Montpellier
Montpellier
Centre Hospitalo-Universitaire de Nantes-Service de Cardiologie
Nantes, 44093
Hopital Pasteur
Nice
Centre Cardiologique du Nord
Saint-Denis
Groupe Hospitalier Rangueil-Larrey CHU
Toulouse, 31403
Centre Hospitalier Universitaire de Nancy-Brabois
Vandœuvre-lès-Nancy
Romania11 sites
Spitalul Judetean Brasov, Sectia de Cardiologie
Brasov
Institutul de Boli Cardiovasculare
Bucharest
Spitalul Caritas, Clinica Medicala
Bucharest
Spitalul de Urgenta Floreasca, Clinica de Cardiologie
Bucharest
Spitalul Universitar de Urgenta Bucuresti
Bucharest
Spitalul Universitar de Urgenta
Bucharest
Institutul Inimii, Prof.N. Stancioiu
Cluj-Napoca
Centrul de Cardiologie Craiova
Craiova
Spitalul Clinic Universitar ,,Sf. Spiridon"
Iași
Spitalul Clinic Judetean Mures
Târgu Mureş
Institutul de Boli Cardiovasculare Timisoara
Timișoara
Sweden10 sites
Avd. for intermedicin
Gothenburg
Medicinkliniken
Gothenburg
Kardiologkliniken
Linköping
Kardiologkliniken
Malmö
Forskiningsenheten,
Mölndal
Enheten for internmedicin, Karolinska Institutet
Stockholm
Hjartkliniken, M84
Stockholm
Kardiologkliniken
Stockholm
Hjartcentrum,
Umeå
Cardiologkliniken, Avd 50F
Uppsala
Spain8 sites
Hospital de Torrecardenas
Almería
Hospital Clinic y Provincial
Barcelona
Hospital de Cruces
Bilbao
Hospital Reina Sofia, in Cordoba
Córdoba
Hospital Doce de Octubre
Madrid
Hospital Severo Ochoa
Madrid
Hospital Universitari de Tarragona Joan XXIII
Tarragona
Hospital General Universitario de Valencia
Valencia
Norway6 sites
Hjerte med. Avd. Haukeland Universitets Sykehus
Bergen
Nordlandsykehuset
Bodø
Hjertemed.avd. Akershus Universitetssykenhus
Nordbyhagen
Diakonhjemmets sykehus Oslo
Oslo
Med. Avd. Sykenhuset Telemark
Skien
Stavanger Helseforskning
Stavanger
United Kingdom5 sites
Bradford Royal Infirmary
Bradford
Castle Hill Hospital
Cottingham
Leeds General Infirmary
Leeds
Northern Manchester General Hospital
Manchester
Scunthorpe General Hospital
Scunthorpe
Belgium4 sites
AZ Middelheim
Antwerp
AZ Imelda Ziekenhuis
Bonheiden
Clinique St Elisabeth Place Louise
Namur
Cliniques UCL Mont-Godinne
Yvoir
About this study
Official title: Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure
The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF).
Read the detailed description
Study Design: Multicenter, randomized, double-blind, placebo-controlled
- Conditions
- Congestive Heart Failure
- Being tested
- Tolvaptan
- Keywords
- chronic heart failure, heart failure
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TolvaptanDrug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2003 (estimated)
- Study startSep 2003
- Primary completionJul 2006
- Study completionJul 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (12)Papers the sponsor has linked to this study.
- Other trials for Congestive Heart FailureStudies of the same condition, open and under way.
- More trials run by Otsuka Pharmaceutical Development & Commercialization, Inc.The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Enrolment
- 3,600 participants
Sponsor and investigators
- Sponsor type
- Industry (pharma, biotech, devices)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00071331
- Sponsor's protocol ID
- 156-03-236
- Status last verified
- May 2012
- First submitted
- 20 Oct 2003
- Last updated
- 3 May 2012
- Results posted
- No
Publications
Oka T, Tighiouart H, McCallum W, Tuttle M, Isaka Y, Konstam MA, Udelson JE, Sarnak MJ. Thresholds of Kidney Function Decline and Congestion Status and Their Relation with Outcomes among Discharged Heart Failure Patients. Clin J Am Soc Nephrol. 2025 Jul 11;20(9):1215-1225. doi: 10.2215/CJN.0000000768.
PubMed 40643971Hejjaji V, Tang Y, Coles T, Jones PG, Reeve BB, Mentz RJ, Spatz ES, Dunlay SM, Caldwell B, Saha A, Tarver ME, Tran A, Patel KK, Henke D, Pina IL, Spertus JA. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure. Circ Heart Fail. 2021 Sep;14(9):e008284. doi: 10.1161/CIRCHEARTFAILURE.120.008284. Epub 2021 Sep 1.
PubMed 34465123Ter Maaten JM, Valente MA, Damman K, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Bloomfield DM, Cotter G, Davison B, Subacius H, van Veldhuisen DJ, van der Meer P, Hillege HL, Gheorghiade M, Voors AA. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Circ Heart Fail. 2016 Jun;9(6):e002845. doi: 10.1161/CIRCHEARTFAILURE.115.002845.
PubMed 27266853Ambrosy AP, Khan H, Udelson JE, Mentz RJ, Chioncel O, Greene SJ, Vaduganathan M, Subacuis HP, Konstam MA, Swedberg K, Zannad F, Maggioni AP, Gheorghiade M, Butler J. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 May;9(5):e002458. doi: 10.1161/CIRCHEARTFAILURE.115.002458.
PubMed 27140204Mentz RJ, Greene SJ, Ambrosy AP, Vaduganathan M, Subacius HP, Swedberg K, Maggioni AP, Nodari S, Ponikowski P, Anker SD, Butler J, Gheorghiade M. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014 May;7(3):401-8. doi: 10.1161/CIRCHEARTFAILURE.113.000840. Epub 2014 Apr 15.
PubMed 24737459Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D, Krasa HB, Maggioni A, Ouyang J, Swedberg K, Zannad F, Zimmer C, Udelson JE; Everest Investigators. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013 Jun;19(6):390-7. doi: 10.1016/j.cardfail.2013.04.001. Epub 2013 May 14.
PubMed 23743487Ambrosy AP, Vaduganathan M, Mentz RJ, Greene SJ, Subacius H, Konstam MA, Maggioni AP, Swedberg K, Gheorghiade M. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Am Heart J. 2013 Feb;165(2):216-25. doi: 10.1016/j.ahj.2012.11.004. Epub 2012 Dec 29.
PubMed 23351825Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):389-98. doi: 10.1161/CIRCOUTCOMES.110.958009. Epub 2011 Jun 21.
PubMed 21693723O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Pina I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M; Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May;159(5):841-849.e1. doi: 10.1016/j.ahj.2010.02.023.
PubMed 20435194Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M; EVEREST Investigators. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11;52(20):1640-8. doi: 10.1016/j.jacc.2008.07.056.
PubMed 18992654Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007 Mar 28;297(12):1332-43. doi: 10.1001/jama.297.12.1332. Epub 2007 Mar 25.
PubMed 17384438Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319. Epub 2007 Mar 25.
PubMed 17384437
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure
- ClinicalTrials.gov ID
- NCT00071331
- Acronym / sponsor ID
- 156-03-236
- Conditions
- Congestive Heart Failure
- Keywords
- chronic heart failure, heart failure
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 3,600 participants
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Industry (pharma, biotech, devices)
- Study start
- Sep 2003
- Primary completion
- Jul 2006 (actual)
- Study completion
- Jul 2006 (actual)
- First posted
- 21 Oct 2003 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF).
Detailed description
Study Design: Multicenter, randomized, double-blind, placebo-controlled
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age greater than or equal to 18 years.
- Current hospitalization for chronic congestive heart failure with admission up to 48 hours prior to randomization. Chronic heart failure is defined as requiring treatment for a minimum of 30 days prior to hospitalization.
- The subject must have signs of extracellular volume expansion, defined as two or more of the following: a) jugular venous distention; b) pitting edema (>1+); or c) dyspnea.
- NYHA Class III or IV at the time of hospitalization.
- Left Ventricular Ejection Fraction < = 40% within one year.
Key exclusion criteria (27 listed)
- Women who will not adhere to the reproductive precautions as outlined in the Informed Consent form.
- Positive urine pregnancy test.
- Inability to provide written informed consent.
- Cardiac surgery within 60 days of potential study enrollment, excluding percutaneous coronary interventions.
- Planned revascularization procedures, electrophysiologic (EP) device implantation, cardiac mechanical support implantation, cardiac transplantation, or other cardiac surgery within 30 days following study enrollment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Tolvaptan | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2012.
- Derived from this study: PubMed 40643971Oka T, Tighiouart H, McCallum W, Tuttle M, Isaka Y, Konstam MA, Udelson JE, Sarnak MJ. Thresholds of Kidney Function Decline and Congestion Status and Their Relation with Outcomes among Discharged Heart Failure Patients. Clin J Am Soc Nephrol. 2025 Jul 11;20(9):1215-1225. doi: 10.2215/CJN.0000000768.
- Derived from this study: PubMed 34465123Hejjaji V, Tang Y, Coles T, Jones PG, Reeve BB, Mentz RJ, Spatz ES, Dunlay SM, Caldwell B, Saha A, Tarver ME, Tran A, Patel KK, Henke D, Pina IL, Spertus JA. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure. Circ Heart Fail. 2021 Sep;14(9):e008284. doi: 10.1161/CIRCHEARTFAILURE.120.008284. Epub 2021 Sep 1.
- Derived from this study: PubMed 27266853Ter Maaten JM, Valente MA, Damman K, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Bloomfield DM, Cotter G, Davison B, Subacius H, van Veldhuisen DJ, van der Meer P, Hillege HL, Gheorghiade M, Voors AA. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. Circ Heart Fail. 2016 Jun;9(6):e002845. doi: 10.1161/CIRCHEARTFAILURE.115.002845.
- Derived from this study: PubMed 27140204Ambrosy AP, Khan H, Udelson JE, Mentz RJ, Chioncel O, Greene SJ, Vaduganathan M, Subacuis HP, Konstam MA, Swedberg K, Zannad F, Maggioni AP, Gheorghiade M, Butler J. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 May;9(5):e002458. doi: 10.1161/CIRCHEARTFAILURE.115.002458.
- Derived from this study: PubMed 24737459Mentz RJ, Greene SJ, Ambrosy AP, Vaduganathan M, Subacius HP, Swedberg K, Maggioni AP, Nodari S, Ponikowski P, Anker SD, Butler J, Gheorghiade M. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014 May;7(3):401-8. doi: 10.1161/CIRCHEARTFAILURE.113.000840. Epub 2014 Apr 15.
- Derived from this study: PubMed 23743487Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D, Krasa HB, Maggioni A, Ouyang J, Swedberg K, Zannad F, Zimmer C, Udelson JE; Everest Investigators. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013 Jun;19(6):390-7. doi: 10.1016/j.cardfail.2013.04.001. Epub 2013 May 14.
- Derived from this study: PubMed 23351825Ambrosy AP, Vaduganathan M, Mentz RJ, Greene SJ, Subacius H, Konstam MA, Maggioni AP, Swedberg K, Gheorghiade M. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Am Heart J. 2013 Feb;165(2):216-25. doi: 10.1016/j.ahj.2012.11.004. Epub 2012 Dec 29.
- Derived from this study: PubMed 21693723Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):389-98. doi: 10.1161/CIRCOUTCOMES.110.958009. Epub 2011 Jun 21.
- Derived from this study: PubMed 20435194O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Pina I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M; Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May;159(5):841-849.e1. doi: 10.1016/j.ahj.2010.02.023.
- Derived from this study: PubMed 18992654Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M; EVEREST Investigators. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11;52(20):1640-8. doi: 10.1016/j.jacc.2008.07.056.
- Derived from this study: PubMed 17384438Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007 Mar 28;297(12):1332-43. doi: 10.1001/jama.297.12.1332. Epub 2007 Mar 25.
- Derived from this study: PubMed 17384437Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319. Epub 2007 Mar 25.
Related trials for Congestive Heart Failure
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
378 sites in 18 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Tolvaptan in people with Congestive Heart Failure, run by Otsuka Pharmaceutical Development & Commercialization, Inc. at 378 sites in 18 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 27 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 378 sites in United States, Russia, Germany, Argentina, Canada and 13 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00071331, which also lists 12 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2012.